Twice-daily amprenavir 1200 mg versus amprenavir 600 mgritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients 英文论文文献.docVIP

BMC Infectious Diseases BioMedCentral Research article Open Access Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients Jeffrey P Nadler*1, Joseph C Gathe2, Richard B Pollard3, Gary J Richmond4, Qiming Liao5, Sandy Griffith5, C Tracey Lancaster5, Jaime E Hernandez5, Keith A Pappa5 and the ESS40011 (STARR) Study Team Address: 1University of South Florida, College of Medicine, Tampa, Florida, USA, 2Park Plaza Hospital, Houston, Texas, USA, 3University of Texas Medical Branch, Galvest